Myriad Receives FDA Approval of myChoice CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Advanced Ovarian Cancer

    NEXT STORY
    OpGen CEO and Chairman of the Board Issue Letters to Stockholders
    PREV STORY
    Amryt Pharma Plc – Full Year 2019 RESULTS
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Latin American Disinfectant Sprays & Wipes Market 2019-2028 – Rising Complications from Healthcare-Associated Infections and COVID-19

    author_avatar
    NASDAQ Market News

    Heat Biologics Announces Proposed Public Offering of Common Stock

    DURHAM, N.C., March 22, 2017 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a ...

    author_avatar
    NASDAQ Market News

    Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose Monitoring

    SANTA CLARA, Calif., Nov. 23, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary ...

    author_avatar
    NASDAQ Market News